Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma Using Gemcitabine Plus S-1 Combined with PD-1 Inhibitors: a Case Report
FRONTIERS IN ONCOLOGY（2025）
Key words
intrahepatic cholangiocarcinoma,conversion therapy,case report,immunotherapy combined therapy,PD-1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined